Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct

Fig. 3

Inhibition of A549 tumor growth by various treatments in vivo. a Images of the tumor-bearing mice of each group. b Images of the tumors of each group at the end of treatments. c The mean tumor volume of each group over the 18-day treatment period. d Tumor wet weights of each group were measured after the animals were killed. Data was shown as mean ± SD obtained from each group. * P < 0.05 vs Mock group, ** P < 0.01 vs Mock group, ΔP < 0.05 vs HM-3 + shScr-V group

Back to article page